1. Home
  2. NVO
  3. NVO News

Latest Novo Nordisk A/S (NVO) News on July 12, 2025

WeightWatchers Has Exited Bankruptcy. How Should You Play WW Stock Here?
NVO

Barchart

a day ago

WeightWatchers Has Exited Bankruptcy. How Should You Play WW Stock Here?

June in Review: 14 Top Health Press Releases
NVO

PR Newswire

a day ago

June in Review: 14 Top Health Press Releases

Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.
NVO

Barrons.com

a day ago

Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.

Novo Nordisk (NVO) Beats Stock Market Upswing: What Investors Need to Know
NVO

Zacks

2 days ago

Novo Nordisk (NVO) Beats Stock Market Upswing: What Investors Need to Know

Lilly Down More Than 15% in a Year: Time to Buy, Sell or Hold?
NVO

Zacks

2 days ago

Lilly Down More Than 15% in a Year: Time to Buy, Sell or Hold?

The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo Fisher Scientific and FONAR
NVO

Zacks

2 days ago

The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo Fisher Scientific and FONAR

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly
NVO

Motley Fool

3 days ago

3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly

Top Research Reports for SAP, Novo Nordisk & Thermo Fisher
NVO

Zacks

3 days ago

Top Research Reports for SAP, Novo Nordisk & Thermo Fisher

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?
NVO

Zacks

3 days ago

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Novo Nordisk Receives Boost on $2.34B Italian Factory
NVO

Insider Monkey

3 days ago

Novo Nordisk Receives Boost on $2.34B Italian Factory

Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk
NVO

The Wall Street Journal

3 days ago

Stocks to Watch Wednesday: Freeport-McMoRan, UnitedHealth, Novo Nordisk

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck
NVO

GlobeNewswire

3 days ago

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck

TD Cowen Keeps Buy on Novo Nordisk (NVO)
NVO

Insider Monkey

3 days ago

TD Cowen Keeps Buy on Novo Nordisk (NVO)

Revived WeightWatchers Rallies, In 'Strongest Position In Years'
NVO

Investor's Business Daily

4 days ago

Revived WeightWatchers Rallies, In 'Strongest Position In Years'

NVO

MT Newswires

4 days ago

Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs

NVO

MT Newswires

4 days ago

Novo Nordisk Seeks EU Approval for New, Higher Dose of Wegovy

Anti-Obesity Drugs Market Research and Forecast Report 2025 | Market to Surpass $120 Billion by 2034 - Increased Strategic Merger and Initiatives to Meet Rising Demand
NVO

GlobeNewswire

4 days ago

Anti-Obesity Drugs Market Research and Forecast Report 2025 | Market to Surpass $120 Billion by 2034 - Increased Strategic Merger and Initiatives to Meet Rising Demand

Novo and Lilly compete in India as obesity drugs demand hikes
NVO

Reuters Videos

5 days ago

Novo and Lilly compete in India as obesity drugs demand hikes

Why Novo Nordisk (NVO) is a Top Value Stock for the Long-Term
NVO

Zacks

5 days ago

Why Novo Nordisk (NVO) is a Top Value Stock for the Long-Term

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down
NVO

Pharma Voice

5 days ago

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down

2 Stocks to Buy on the Dip and Hold for 10 Years
NVO

Motley Fool

6 days ago

2 Stocks to Buy on the Dip and Hold for 10 Years

PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?
NVO

Zacks

8 days ago

PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?

Are You Looking for a High-Growth Dividend Stock?
NVO

Zacks

8 days ago

Are You Looking for a High-Growth Dividend Stock?

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?
NVO

Zacks

8 days ago

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
NVO

Zacks

8 days ago

Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?

Novo Nordisk Teams With WeightWatchers to Expand Wegovy Access
NVO

Insider Monkey

8 days ago

Novo Nordisk Teams With WeightWatchers to Expand Wegovy Access

Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst Questions
NVO

StockStory

8 days ago

Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst Questions

Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns.
NVO

Barrons.com

8 days ago

Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns.

Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report
NVO

Benzinga

9 days ago

Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report

Pfizer Trades Above 50-Day Average for a Month: Time to Buy?
NVO

Zacks

9 days ago

Pfizer Trades Above 50-Day Average for a Month: Time to Buy?

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
NVO

Zacks

10 days ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements
NVO

GlobeNewswire

10 days ago

Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements

Is Hims & Hers Stock in Trouble?
NVO

Motley Fool

10 days ago

Is Hims & Hers Stock in Trouble?

2 Growth Stocks to Buy Hand Over Fist in July
NVO

Motley Fool

10 days ago

2 Growth Stocks to Buy Hand Over Fist in July

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
NVO

Motley Fool

10 days ago

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

NVO

MT Newswires

11 days ago

Novo Nordisk, WeightWatchers Expand Collaboration for Enhanced Access to Wegovy

Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note
NVO

Zacks

11 days ago

Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
NVO

GlobeNewswire

11 days ago

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care

NVO

MT Newswires

11 days ago

Sector Update: Health Care Stocks Advance Tuesday Afternoon

NVO

MT Newswires

11 days ago

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday

NVO

MT Newswires

11 days ago

Market Chatter: Novo Nordisk Executives Ignored Warnings Against Wegovy Launch

How Novo Nordisk misread the US market for its weight loss sensation
NVO

Reuters

11 days ago

How Novo Nordisk misread the US market for its weight loss sensation

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
NVO

Investor's Business Daily

12 days ago

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?

Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)
NVO

Zacks

12 days ago

Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)

Hardman Johnston Global Equity Sold Novo Nordisk (NVO) due to Weak Script Trends
NVO

Insider Monkey

12 days ago

Hardman Johnston Global Equity Sold Novo Nordisk (NVO) due to Weak Script Trends

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
NVO

Zacks

12 days ago

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)
NVO

Motley Fool

13 days ago

This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)

Novo Nordisk teams up with WeightWatchers in latest telehealth push
NVO

Pharmaceutical Technology

15 days ago

Novo Nordisk teams up with WeightWatchers in latest telehealth push

Weekly Recap: 12 Health Press Releases You Need to See
NVO

PR Newswire

15 days ago

Weekly Recap: 12 Health Press Releases You Need to See

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
NVO

Motley Fool

15 days ago

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?

Novo Nordisk says WeightWatchers will sell Wegovy
NVO

Reuters Videos

15 days ago

Novo Nordisk says WeightWatchers will sell Wegovy

NVO

MT Newswires

16 days ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Why Is Hims & Hers Health (HIMS) Stock Soaring Today
NVO

StockStory

16 days ago

Why Is Hims & Hers Health (HIMS) Stock Soaring Today

Telehealth Firm Pushes Back on Novo Nordisk's Semaglutide Ruling
NVO

GuruFocus.com

16 days ago

Telehealth Firm Pushes Back on Novo Nordisk's Semaglutide Ruling

NVO

MT Newswires

16 days ago

Sector Update: Health Care Stocks Increase in Afternoon Trading

Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025
NVO

Pharmaceutical Technology

16 days ago

Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025

NVO

MT Newswires

16 days ago

Update: Novo Nordisk Under Probe by Spanish Health Ministry Over Advertising of Weigh-Loss Drug

Novo Nordisk A/S (NVO): A Bull Case Theory
NVO

Insider Monkey

17 days ago

Novo Nordisk A/S (NVO): A Bull Case Theory

Why Shares in Novo Nordisk Lost Weight Today
NVO

Motley Fool

17 days ago

Why Shares in Novo Nordisk Lost Weight Today

General Mills earnings, Novo Nordisk stock slips, Micron results
NVO

Yahoo Finance Video

17 days ago

General Mills earnings, Novo Nordisk stock slips, Micron results

Eli Lilly and Company (LLY) Is Going To Be A “Trillion-Dollar Market Cap,” Says Jim Cramer
NVO

Insider Monkey

17 days ago

Eli Lilly and Company (LLY) Is Going To Be A “Trillion-Dollar Market Cap,” Says Jim Cramer

Novo Nordisk A/S (NVO): “How Could They Be So Far Behind?,” Wonders Jim Cramer
NVO

Insider Monkey

17 days ago

Novo Nordisk A/S (NVO): “How Could They Be So Far Behind?,” Wonders Jim Cramer

NVO

MT Newswires

17 days ago

Sector Update: Health Care Stocks Mixed Premarket Wednesday

Novo Nordisk split puts Hims & Hers future in question
NVO

Yahoo Finance

17 days ago

Novo Nordisk split puts Hims & Hers future in question

NVO

MT Newswires

17 days ago

Sector Update: Health Care

NVO

MT Newswires

17 days ago

Hims & Hers to Keep Offering Weight-Loss Shots After Novo Nordisk Partnership Termination, CEO Says

NVO

MT Newswires

17 days ago

Novo Nordisk Under Probe by Spanish Health Ministry Over Advertising of Weigh-Loss Drug

United States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption
NVO

GlobeNewswire

17 days ago

United States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption

Novo Nordisk Fast-Tracks Amycretin to Phase 3 for Obesity Treatment
NVO

Insider Monkey

17 days ago

Novo Nordisk Fast-Tracks Amycretin to Phase 3 for Obesity Treatment

Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates
NVO

Insider Monkey

17 days ago

Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
NVO

Pharmaceutical Technology

18 days ago

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know
NVO

Motley Fool

18 days ago

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Fiserv Connecting Thousands of Banks to Crypto with New Stablecoin Platform
NVO

The Daily Upside

18 days ago

Fiserv Connecting Thousands of Banks to Crypto with New Stablecoin Platform

Novo Nordisk Backs Away From Hims & Hers Partnership
NVO

The Daily Upside

18 days ago

Novo Nordisk Backs Away From Hims & Hers Partnership

Markets Stay Relatively Calm as Fragile Ceasefire Deal Follows Missile Strikes
NVO

The Daily Upside

18 days ago

Markets Stay Relatively Calm as Fragile Ceasefire Deal Follows Missile Strikes

NVO

Morningstar Research

18 days ago

Analyst Report: Novo Nordisk A/S

Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know
NVO

Zacks

19 days ago

Novo Nordisk (NVO) Stock Sinks As Market Gains: What You Should Know

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.
NVO

Barrons.com

19 days ago

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

NVO

MT Newswires

19 days ago

Sector Update: Health Care Stocks Flat to Lower Premarket Monday

IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs
NVO

Investor's Business Daily

19 days ago

IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs

NVO

MT Newswires

19 days ago

Sector Update: Health Care

NVO

MT Newswires

19 days ago

Novo Nordisk Ends Wegovy Relationship With Hims & Hers Over Sales of Compounded Drugs

Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership
NVO

Barrons.com

19 days ago

Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership

NVO

Investing.com

19 days ago

Hims & Hers stock falls after Novo Nordisk ends weight loss drug pact

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
NVO

PR Newswire

19 days ago

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing

Novo Nordisk ends Hims & Hers collaboration over Wegovy weight loss drug
NVO

Reuters

19 days ago

Novo Nordisk ends Hims & Hers collaboration over Wegovy weight loss drug

Novo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA
NVO

GlobeNewswire

21 days ago

Novo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
NVO

GlobeNewswire

21 days ago

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess weight, published in The Lancet
NVO

PR Newswire

21 days ago

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess weight, published in The Lancet

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
NVO

Reuters

22 days ago

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl
NVO

Investor's Business Daily

22 days ago

How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl

London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape
NVO

Pharmaceutical Technology

22 days ago

London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
NVO

Zacks

22 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Ricks Is the King of Pharma, Thanks to Lilly’s Zepbound
NVO

Barrons.com

22 days ago

Ricks Is the King of Pharma, Thanks to Lilly’s Zepbound

NVO

Argus Research

22 days ago

Analyst Report: Novo Nordisk

NVO

Argus Research

22 days ago

Market Digest: NVO, CPB

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand
NVO

Reuters

22 days ago

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand

What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?
NVO

Zacks

23 days ago

What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?

Why Novo Nordisk (NVO) is a Great Dividend Stock Right Now
NVO

Zacks

24 days ago

Why Novo Nordisk (NVO) is a Great Dividend Stock Right Now

Can Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?
NVO

Zacks

24 days ago

Can Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?

Share on Social Networks: